|Day Low/High||132.81 / 135.71|
|52 Wk Low/High||122.49 / 178.86|
McKesson Corporation (NYSE:MCK) will release financial results for its second fiscal quarter ended September 30, 2018 on Thursday, October 25, 2018, prior to the opening of trading on the New York Stock Exchange.
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
McKesson Corporation (NYSE:MCK) today announced that its Board of Directors has elected Dominic Caruso as a new independent director, effective September 12, 2018.
A study of analyst recommendations at the major brokerages shows that McKesson Corp is the #55 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.
The most recent short interest data has been released for the 08/15/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
McKesson Corporation (NYSE:MCK) announced that Britt Vitalone, the company's executive vice president and chief financial officer, will present at the Morgan Stanley Global Healthcare Conference in New York at 10:30 a.
Insys Therapeutics, Cardinal Health and McKesson are just some of the public companies that could be affected by the Trump administration directive.
Contrarians who bought several "dead men walking" retailers have pocketed big gains by defying conventional wisdom.
The healthcare space continues to be ripe for investment opportunity. Here are three stocks that won't make your portfolio sick.
Buy Cardinal Health and give it time for the market to reassess the industry.
Rite Aid's generic drug purchasing power is likely much lower than previously forecast. What does this mean for CVS? Here are some answers.
McKesson Corporation (NYSE:MCK) today announced that Brian S. Tyler, Ph.
Micron Technology, Intel and Lam Research are good buys on this heat in semiconductors.
McKesson Corporation (NYSE:MCK) today reported that revenues for the first quarter ended June 30, 2018, were $52.
McKesson Corporation (NYSE:MCK) today announced preliminary voting results from its Annual Meeting of Stockholders, held earlier today in Irving, Texas.
McKesson Corporation (NYSE:MCK) will release financial results for its first fiscal quarter ended June 30, 2018 on Thursday, July 26, 2018, prior to the opening of trading on the New York Stock Exchange.
McKesson Corporation (NYSE:MCK) today reaffirmed its Adjusted Earnings per diluted share guidance of $13.
These stocks are selling at historically low earnings multiples, but have raised their dividends for decades.
E-commerce company expands to keep up with rapidly growing brand demand
McKesson Corporation (NYSE:MCK), a global leader in healthcare supply chain management solutions, announced today that it has completed the previously announced acquisition of Medical Specialties Distributors.
Relief is on the way, and there's an inexpensive beneficiary out in California.
McKesson Corporation (NYSE:MCK) today reported that revenues for the fourth quarter ended March 31, 2018, were $51.
President Trump delivered a highly-anticipated speech on lowering the cost of drugs for Americans on Friday afternoon.
It has been yet another long week on Wall Street. On Friday, investors are greeted with a mild Nvidia earnings related selloff. Be on the lookout for valuation-based tech stock downgrades in the week ahead.
Since taking office, President Trump has talked big on reining in drug prices, but the administration's lack of action leaves most expecting a May 11 speech that tastes like a nothing burger.
A study of analyst recommendations at the major brokerages shows that McKesson Corp is the #44 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity. To make that list, a stock must have repurchased at least 5% of its outstanding shares over the trailing twelve month period.
One drug distribution executive appearing before a House Committee to answer for shipping millions of doses of opioids into West Virginia apologized and another said his company had a hand in the crisis.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.